St Jude ends M&A dry spell with force-sensing heart ablation tech buy
This article was originally published in Clinica
Executive Summary
St Jude Medical has acquired Endosense, a privately-held Swiss company specializing in force-sensing catheter ablation technologies. The acquisition is St Jude’s first significant purchase after a near three-year M&A dry spell, and will strengthen its offerings for cardiac arrhythmia treatment, including the fast-growing atrial fibrillation (AF) segment.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.